CAR T-Cells: Refining CLL Therapy With Clinical Trials

preview_player
Показать описание
Brian Koffman, MDCM, MSEd, shares insight on his current relapse of chronic lymphocytic leukemia (CLL) and discusses the potential value of chimeric antigen receptor (CAR) T-cell therapy, which he will be receiving in an upcoming clinical trial.

CURE: Combining science and humanity to make cancer understandable.
Рекомендации по теме